Specific alteration of the Bax/Bcl2 ratio and cytochrome c without execution of apoptosis in the hippocampus of aged baboons

Restorative Neurology and Neuroscience

Volumn 23, Issue 1, 2005, Pages 1-9

  Thees, S ^a   Hubbard, G B ^b   Winckler, J ^a   Schultz, C ^a   Rami, A ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b Dept of Laboratory Animal Medicine ^*  (United States)

Author keywords

Ageing; Apoptosis; Baboon; Bax; Bcl 2; Cytochrome c; Hippocampus

Indexed keywords

ANTIBODY; CASPASE 3; CYTOCHROME C; PROTEIN BAX; PROTEIN BCL 2;

ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BABOON; FEMALE; HIPPOCAMPUS; IMMUNOCYTOCHEMISTRY; IMMUNOREACTIVITY; MALE; NICK END LABELING; NONHUMAN; PATHOLOGY; PRIORITY JOURNAL; UPREGULATION;

AGING; ANIMALS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CYTOCHROMES C; FEMALE; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; MALE; PAPIO; PROTO-ONCOGENE PROTEINS C-BCL-2;

EID: 17244381089     PISSN: 09226028     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. E.S. Alnemri, D.J. Livingston, D.W. Nicholson, G. Salvesen, N.A. Thornberry, W.W. Wong and J. Yuan, Human ICE/CED-3 protease nomenclature, Cell 87 (1996), 171.
2. G. Barja, The flux of free radical attack through mitochondrial DNA is related to aging rate, Aging 12 (2000), 342-355.
3. H. Braak and E. Braak, Staging of Alzheimer-related cortical destruction, Int. Psychogeriatr. Suppl. 1 (1997), 257-261.
4. E. Bossy-Wetzel, D.D. Newmeyer and D.R. Green, Mitochondrial cytochrome c release in apoptosis occurs upstream of DEVD-specific caspase activation and independently of mitochondrial transmembrane depolarization, EMBO J 17 (1998), 37-49.
5. G. Botez and A. Rami, Immunoreactivity for bcl-2 and c-jun/AP1 in hippocampal corpora amylacea after ischaemia in human, Neuropath. and Appl. Neurobiol. 27 (2001), 474-480.
6. E.H. Cheng, D.G. Kirsch, R.J. Clem, R. Ravi, M.B. Kastan, A. Bedi, K. Ueno and J.M. Hardwick, Conversion of bcl-2 to a bax-like death effector by caspases, Science 278 (1997), 1966-1968.
7. A. Copani, V. Bruno, G, Battaglia, G. Leanza, R. Pellitteri, A. Russo, S. Stanzani and F. Nicoletti, Activation of metabotropic glutamate receptors protects cultured neurons against apoptosis induced by beta-amyloid peptide, Mol. Pharmacol. 47 (1995), 890-897.
8. Q.L. Deveraux, R. Takahashi, G.S. Salvesen and J.C. Reed, X-linked IAP is a direct inhibitor of cell-death proteases, Nature 388 (1997), 300-304.
9. M. Dragunow, R.L. Faull, P. Lawlor, E.J. Beilharz, K. Single-ton, E.B. Walker and E. Mee, In situ evidence for DNA fragmentation in Huntington's disease striatum and Alzheimer's disease temporal lobes, Neuroreport 6 (1995), 1053-1057.
10. M. Enari, H. Sakahira, H. Yokoyama, K. Okawa, A. Iwamatsu and S. Nagata, A caspase-activated DNAse that degrades DNA during apoptosis, and its inhibitor ICAD, Nature 391 (1998), 43-50.
11. G. Forloni, R. Chiesa, S. Smiroldo, L. Verga, M. Salmona, F. Tagliavini and N. Angeretti, Apoptosis mediated neurotoxicity induced by chronic application of beta amyloid fragment 25-35, Neuroreport 4 (1993), 523-526.
12. Y. Gavrieli, Y. Sherman and S.A. Ben-Sasson, Identification of programmed cell death in situ via specific labeling of nuclear DNA-fragmentation, J. Cell Biol. 119 (1992), 493-501.
13. B.R. Hu, C.L. Liu, Y. Ouyang, K. Blomgren and B.K. Siesjo, Involvement of caspase-3 in cell death after hypoxia-ischemia declines during brain maturation, Cereb. Blood Flow Metab. 20 (2000), 1294-1300.
14. R. Jemmerson, J. Liu, D. Hausauer, K.P. Lam, A. Mondino and R.D. Nelson, A conformational change in cytochrome c of apoptotic and necrotic cells is detected by monoclonal antibody binding and mimicked by association of the native antigen with synthetic phospholipid vesicles, Biochemistry 38 (1999), 3599-3609.
15. J.M. Jurgensmeier, Z. Xie, Q. Deveraux, L. Ellerby, D. Bredesen and J.C. Reed, Bax directly induces release of cytochrome c from isolated mitochondria, Proc. Natl. Acad. Sci. USA 95 (1998), 4997-5002.
16. R.M. Kluck, E. Bossy-Wetzel, D.R. Green and D.D. Newmeyer, The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis, Science 275 (1997), 1081-1082.
17. K. Kuida, T. S. Zheng, S. Na, C. Kuan, D. Yang, H. Karasuyama, P. Rakic and R.A. Flavell, Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice, Nature 384 (1996), 368-372.
18. H. Lassmann, C. Bancher, H. Breitschopf, J. Wegiel, M. Bobinski, K. Jellinger and H.M. Wisniewski, Cell death in Alzheimer's disease evaluated by DNA fragmentation in situ, Acta Neuropathol 89 (1995), 35-41.
19. X. Liu, C. N. Kim, J. Pohl and X. Wang, Purification and characterization of an interleukin-1beta-converting enzyme family protease that activates cysteine protease P32 (CPP32), J. Biol. Chem. 271 (1996), 13371-13376.
20. B.P. Lockhart, F. Hamedi-Sangsari, J. Vignon, A. Privat and J. Vila, A N-methyl-D-aspartate receptor-mediated neurotoxic effect of aspartate-based hydroxamate compounds in rat primary neuronal cultures, Brain Res 670 (1995), 313-316.
21. D. Marzulli, G. La Piana, L. Cafagno, E. Fransvea and N. E. Lofrumento, Proton translocation linked to the activity of the bi-trans-membrane electron transport chain, Arch. Biochem. Biophys. 319 (1995), 36-48.
22. M. Masson, V. Rolli, F. Dantzer, C. Trucco V. Schreiber, S. Fribourg, M. Molinete, A. Ruf, E.A. Miranda, C. Niedergang et al., Poly(ADP-ribose) polymerase: structure-function relationship, Biochimie 77 (1995), 456-461.
23. D.W. Nicholson, A. Ali, N.A. Thornberry, J.P. Vaillancourt, C.K. Ding, M. Gallant, Y. Gareau, P.R. Griffin, M. Labelle and Y.A. Lazebnik, Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis, Nature 376 (1995), 37-43.
24. F.W. Ng, M. Nguyen, T. Kwan, P.E. Branton, D.W. Nicholson, J.A. Cromlish and G.C. Shore, p28 Bap31, a Bcl-2/Bcl-XL- and procaspase-8-associated protein in the endoplasmic reticulum, J. Cell Biol. 139 (1997), 327-338.
25. G. Olivetti, G. Giordano, D. Corradi, M. Melissari, C. Lagrasta, S.R. Gambert and P. Anversa, Gender differences and aging: effects on the human heart, J. Am. Coll. Cardiol. 26 (1995), 1068-1079.
26. S. Phaneuf and C. Leeuwenburgh, Cytochrome c release from mitochondria in the aging heart: a possible mechanism for apoptosis with age, Am. J. Physiol. Regul. Integr. Comp. Physiol. 282 (2002), 423-430.
27. A.G. Porter and R.U. Janicke, Emerging roles of caspase-3 in apoptosis, Cell Death Differ 6 (1999), 99-104.
28. A. Rami, R. Agarwal, G. Botez and J. Winckler, μ-Calpain Activation, DNA-Fragmentation, and synergistic effects of caspase- and calpain-inhibitors in protecting hippocampal neurons from ischemic damage, Brain Res 866 (2000), 299-312.
29. A. Rami, Cross-Talk between calpain and caspase-3 in response to cerebral ischemia, Restor Neurol. and Neurosci. 16 (2000), 63.
30. A. Rami, Calpain and caspase in cerebral ischemia and neuronal apoptosis the calpain-calpastatin-caspase-hypothesis, Neurobiology of Disease 13 (2003), 75-88.
31. A. Rami, J. Jansen, I. Giesser and J. Winckler, Post-ischemic activation of caspase-3 in the rat hippocampus: Evidence of an axonal and dendritic localisation, Neurochemistry International 43 (2003), 211-223.
32. A. Rami, J. Sims, G. Botez and J. Winckler, Spatial resolution of phospholipid scramblase 1 (PLSCR1), caspase-3 activation and DNA-fragmentation in the human hippocampus after cerebral ischemia, Neurochemistry International 43 (2003), 79-87.
33. C. Schultz, F. Dehghani, G.B. Hubbard, D.R. Thal, G. Struckhoff, E. Braak and H. Braak, Filamentous tau pathology in nerve cells, astrocytes, and oligodendrocytes of aged baboons, J. Neuropathol. Exp. Neurol. 59 (2000), 39-52.
34. C. Schultz, G. B. Hubbard, U. Rüb, E. Braak and H. Braak, Age-related progression of tau pathology in brains of baboons, Neurobiol. Aging 21 (2001), 905-912.
35. C. Schultz, K. del Tredici, U. Rüb, E. Braak, G.B. Hubbard and H. Braak, The brain of the aging baboon: A nonhuman primate model for neuronal and glial tau pathology, in: Aging in Non-human Primates, Interdiscipl. Top Gerontol. Basel, Karger, (Vol. 31), J.M. Erwin and P.R. Hof, eds, 2002, pp. 118-129.
36. J.H. Su, A.J. Anderson, B.J. Cummings and C.W. Cotman, Immunohistochemical evidence for apoptosis in Alzheimer's disease, Neuroreport 5 (1994), 2529-2533.
37. N.A. Thornberry and Y. Lazebnik, Caspases: enemies within, Science 281 (1998), 1312-1316.
38. K. Uchida, H. Nakayama and N. Goto, Pathological studies on cerebral amyloid angiopathy, senile plaques and amyloid deposition in visceral organs in aged dogs, J. Vet. Med. Sci. 53 (1991), 1037-1042.
39. J. Varkey, P. Chen, R. Jemmerson and J.M. Abrams, Altered cytochrome c display precedes apoptotic cell death in Drosophila, J. Cell Biol. 144 (1999), 701-710.
40. A.H. Wyllie, Cell death: the significance of apoptosis, Int. Rev. Cytol. 68 (1980), 251-306.
41. A.H. Wyllie, Apoptosis: cell death in tissue regulation, J. Pathol. 153 (1987), 313-316.
42. Y. Zhang, C. Goodyer and A. LeBlanc, Selective and Protracted Apoptosis in Human Primary Neurons Microinjected with Active Caspase-3, -6, -7, and -8, J. Neurosci. 20 (2000), 8384-8389.
43. M. Zhao, J. Su, E. Head and C.W. Cotman, Accumulation of caspase cleaved amyloid precursor protein represents an early neurodegenerative event in aging and in Alzheimer's disease, Neurobiol Dis 14 (2003), 391-403.
44. Y. Zhu, S. Roth-Eichhorn, N. Braun, C. Culmsee, A. Rami and J. Krieglstein, The expression of transforming growth factor-beta1 (TGF-beta1) in hippocampal neurons: a temporary upregulated protein level after transient forebrain ischemia in the rat, Brain Res 866 (2000), 286-298.
45. M. Zoratti and I. Szabo, The mitochondrial permeability transition, Biochim. Biophys. Acta 1241 (1995), 139-176.